Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jude Fitzgibbon

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Transformation of indolent B-cell lymphomasSilvia Montoto, Jude Fitzgibbon
British Journal of Haematology|January 5, 2008
Familial myelodysplasia and acute myeloid leukaemia--a reviewCarolyn Owen, Michael Barnett, Jude Fitzgibbon
Expert Opinion on Investigational Drugs|May 27, 2014
Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignanciesJessica Okosun, Graham Packham, Jude Fitzgibbon
Current Opinion in Hematology|June 24, 2010
Molecular signatures in the diagnosis and management of follicular lymphomaDavid Wrench, Silvia Montoto, Jude Fitzgibbon
Current Opinion in Hematology|May 3, 2016
The routes for transformation of follicular lymphomaJessica Okosun, Silvia Montoto, Jude Fitzgibbon
Hematological Oncology|December 17, 2009
The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemiaCarolyn Owen, Jude Fitzgibbon, Peter Paschka
Hematology/Oncology Clinics of North America|June 27, 2020
The Biological Basis of Histologic TransformationEmil A Kumar, Jessica Okosun, Jude Fitzgibbon
British Journal of Haematology|December 22, 2019
AML through the prism of molecular geneticsSarah Charrot, Hannah Armes, Ana Rio-Machin, et al.
Epigenetics|January 21, 2017
Follicular lymphoma, a B cell malignancy addicted to epigenetic mutationsKoorosh Korfi, Sara Ali, James A Heward, et al.
Seminars in Hematology|June 23, 2017
Familial CEBPA-mutated acute myeloid leukemiaKiran Tawana, Ana Rio-Machin, Claude Preudhomme, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Transformation of indolent B-cell lymphomasSilvia Montoto, Jude Fitzgibbon
British Journal of Haematology|January 5, 2008
Familial myelodysplasia and acute myeloid leukaemia--a reviewCarolyn Owen, Michael Barnett, Jude Fitzgibbon
Expert Opinion on Investigational Drugs|May 27, 2014
Investigational epigenetically targeted drugs in early phase trials for the treatment of haematological malignanciesJessica Okosun, Graham Packham, Jude Fitzgibbon
Current Opinion in Hematology|June 24, 2010
Molecular signatures in the diagnosis and management of follicular lymphomaDavid Wrench, Silvia Montoto, Jude Fitzgibbon
Current Opinion in Hematology|May 3, 2016
The routes for transformation of follicular lymphomaJessica Okosun, Silvia Montoto, Jude Fitzgibbon
Hematological Oncology|December 17, 2009
The clinical relevance of Wilms Tumour 1 (WT1) gene mutations in acute leukaemiaCarolyn Owen, Jude Fitzgibbon, Peter Paschka
Hematology/Oncology Clinics of North America|June 27, 2020
The Biological Basis of Histologic TransformationEmil A Kumar, Jessica Okosun, Jude Fitzgibbon
British Journal of Haematology|December 22, 2019
AML through the prism of molecular geneticsSarah Charrot, Hannah Armes, Ana Rio-Machin, et al.
Epigenetics|January 21, 2017
Follicular lymphoma, a B cell malignancy addicted to epigenetic mutationsKoorosh Korfi, Sara Ali, James A Heward, et al.
Seminars in Hematology|June 23, 2017
Familial CEBPA-mutated acute myeloid leukemiaKiran Tawana, Ana Rio-Machin, Claude Preudhomme, et al.
Pageof 9